Offer - Urjas Oil for just ₹ 1 X
Mycurit, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Tuberculosis.
The optimal dosage of Mycurit is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Mycurit also has some side effects, the most common being Dizziness, Difficulty breathing, Difficulty talking. Usually, these side effects of Mycurit go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Mycurit's effect during pregnancy is Moderate and Moderate while nursing. Warnings related to Mycurit's effects on the liver, heart and kidney, if any, have been listed below.
Mycurit can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Mycurit in conditions like Kidney Disease, Heart Disease. Other conditions have been mentioned below in the Mycurit contraindications section.
Drug reaction of Mycurit with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Mycurit is considered not safe while driving, and is not addictive.
Mycurit is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Mycurit safe for pregnant women?
Mycurit may have some side effects during pregnancy. Pregnant women should discontinue the use of Mycurit, and talk to their doctor, if they notice any discomfort.
Is the use of Mycurit safe during breastfeeding?
Mycurit can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Mycurit on the Kidneys?
Mycurit may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Mycurit on the Liver?
The liver can be affected by Mycurit. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Mycurit only after medical advice.
What is the effect of Mycurit on the Heart?
Mycurit can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Mycurit should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Mycurit unless your doctor advises you to do so -
Is this Mycurit habit forming or addictive?
Mycurit does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Mycurit can make you feel drowsy.
Is it safe?
Mycurit should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Mycurit for mental disorders.
Interaction between Food and Mycurit
You can take Mycurit with food.
Interaction between Alcohol and Mycurit
Consumption of alcohol and Mycurit together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rifadin (rifampin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 767-768
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Isoniazid
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 765-767
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 715-716
Product Description [Internet]: RIFADIN®. USFDA
Product Description [Internet]: ISONIAZID. Alliance Pharmaceuticals Limited